Capri Global Capital Financial Results

Capri Global Capital Debt & Borrowing: ₹1.42 Cr

Capri Global paid interest on four listed NCD series ahead of their due dates, totalling Rs.1.42 Crore. The Reg 57 certificate reports no payment changes or delays.

Value

₹1.42 Cr

Capri Global Capital Earnings Call Transcript: Key Takeaways

Strong core performance overshadowed by a significant gold loan delinquency spike driven by product structural shifts. Management maintains aggressive expansion targets despite asset quality headwinds in rural segments.

Capri Global Capital Credit Rating

India Ratings affirmed CGCL's credit rating at IND AA- with Positive outlook. A new Rs. 500 Cr bank loan facility was also assigned the same rating.

Capri Global Capital Debt & Borrowing: ₹2.27 Cr

Capri Global Capital paid Rs. 226.85 lakh interest on its Series 16 NCDs on the due date of October 28, 2026. The payment is in line with the debenture terms.

Value

₹2.27 Cr

Capri Global Capital Investor Presentation: Key Takeaways

Q2FY27 PAT ₹4,183mn (+77% YoY), NII ₹8,125mn (+69%), AUM ₹438,785mn (+62%). Cost-income improved to 41.4%. No explicit numeric guidance.

Capri Global Capital Results Update

Capri Global posts record 2QFY27 PAT of Rs 418 crores, up 77% YoY. Consolidated AUM rose 62% to Rs 43,878 crores.

Glittek Granites Q2 FY27 Results: Turns Profitable, Net Profit ₹0.1 Cr

Glittek Granites Ltd reported revenue from operations of ₹0.3 Cr and net profit of ₹0.1 Cr for Q2 FY27.

Key figure

Net profit ₹0.1 Cr

Sudarshan Pharma Industries Q2 FY27 Results: Net Profit ₹8.1 Cr, Up 92.9% YoY

Sudarshan Pharma Industries Ltd reported revenue from operations of ₹217 Cr (+28.5% YoY) and net profit of ₹8.1 Cr (+92.9% YoY) for Q2 FY27.

Key figure

Net profit ₹8.1 Cr · +92.9% YoY

STL Networks Q2 FY27 Results: Net Loss of ₹16.1 Cr, Loss Narrows

STL Networks Ltd reported revenue from operations of ₹270.1 Cr (+17.0% YoY) and a net loss of ₹16.1 Cr for Q2 FY27.

Key figure

Net loss ₹16.1 Cr

RPG Life Sciences Q2 FY27 Results: Net Profit ₹28.2 Cr, Down 23.6% YoY

RPG Life Sciences Ltd reported revenue from operations of ₹211.6 Cr (+16.5% YoY) and net profit of ₹28.2 Cr (-23.6% YoY) for Q2 FY27.

Key figure

Net profit ₹28.2 Cr · -23.6% YoY

Alldigi Tech Q2 FY27 Results: Net Profit ₹26.6 Cr, Up 51.1% YoY

Alldigi Tech Ltd reported revenue from operations of ₹153.3 Cr (+4.0% YoY) and net profit of ₹26.6 Cr (+51.1% YoY) for Q2 FY27.

Key figure

Net profit ₹26.6 Cr · +51.1% YoY

Krishna Defence and Allied Industries Q2 FY27 Results: Net Profit ₹1,532 Cr, Up 71.8% YoY

Krishna Defence and Allied Industries Ltd reported revenue from operations of ₹7,529 Cr (+55.7% YoY) and net profit of ₹1,532 Cr (+71.8% YoY) for Q2 FY27.

Key figure

Net profit ₹1,532 Cr · +71.8% YoY